Skip to main content

Table 2 Comparison of pregnancy outcomes

From: A randomized double blind comparison of atosiban in patients with recurrent implantation failure undergoing IVF treatment

 

Atosiban group

Placebo group

P-value

Relative risk (95% CI)

Positive pregnancy test rate

52.6% (51/97)

44.3% (43/97)

0.250

1.186(0.885–1.589)

Clinical pregnancy rate

50.5% (49/97)

42.3% (41/97)

0.249

1.195(0.881–1.621)

Ongoing pregnancy rate

42.3% (41/97)

35.1% (34/97)

0.302

1.206(0.844–1.723)

Live birth rate

42.3% (41/97)

35.1% (34/97)

0.302

1.206(0.844–1.723)

Miscarriage rate

15.7% (8/51)

16.3% (7/43)

0.938

0.964(0.380–2.441)

Multiple pregnancy rate

21.6% (11/51)

18.6% (8/43)

0.721

1.159(0.513–2.620)

Implantation rate

34.4% (63/183)

29.0% (53/183)

0.261

1.189(0.878–1.608)

Ectopic pregnancy rate

2% (1/51)

2.3% (1/43)

1

0.834(0.054–13.083)

Congenital abnormality rate

0

0

  
  1. Note: Data are percentage (number of positive finding/total number in the group). Chi-square test or Fisher’s exact test were used if appropriate. There were no significant differences between groups